10x Genomics Clinician Researcher Accelerator Program

Clinical research is increasingly driven by the need to understand biological heterogeneity, identify actionable biomarkers, and link molecular mechanisms to patient outcomes. Traditional bulk and low-resolution approaches often mask clinically relevant signals, slowing discovery and translation. 10x Genomics technologies accelerate clinical research by enabling cell-resolved and spatially resolved insights at scale at earlier in the research pipeline.

A targeted Clinician Researcher Accelerator Program designed to support medically qualified clinician researchers in generating high-impact spatial and single-cell data, with dedicated support and preferential pricing to fast-track translational research.

The Clinician Researcher Accelerator Program is a limited-time initiative supporting medically qualified clinician researchers who are looking to integrate spatial transcriptomics and single-cell profiling into their research. Successful applicants will receive access to dedicated technical guidance, and preferential pricing to help generate robust pilot data for translational and clinically focused studies.

Many clinical samples including tumours, immune tissues, and biopsies, are highly heterogeneous. Bulk profiling averages signals across cell populations, obscuring rare or disease-driving cell states.

Chromium Single Cell technologies enable researchers to:

• Identify rare or pathogenic cell populations
• Characterise immune cell diversity and activation states
• Study patient-to-patient variability at cellular resolution

Clinical impact:
Earlier identification of clinically relevant subpopulations improves hypothesis generation, patient stratification strategies, and biomarker discovery.

Understanding where cells are located within tissue is critical for clinical interpretation, particularly in oncology, immunology, and pathology-driven research.

Visium Spatial Gene Expression allows researchers to:

• Map gene expression within intact tissue sections
• Correlate molecular patterns with histology
• Identify spatially distinct disease niches

Clinical impact:
Spatial context strengthens biological interpretation, supports translational relevance, and enables more compelling mechanistic narratives for grants and publications.

Discovery technologies are most powerful when paired with targeted validation in clinically relevant samples.

Xenium In Situ enables:

• High-plex, single-cell resolution spatial validation
• Direct visualisation of clinically relevant gene signatures
• Confirmation of biomarkers within preserved tissue architecture

Clinical impact:
Xenium supports the transition from discovery to validation which is a critical step for translational studies, diagnostic development, and clinical adoption.

Clinical research is often constrained by:

• Limited sample availability
• Ethical and governance considerations
• The need to justify scale and cost upfront

10x Genomics platforms are well suited to small, high-information pilot studies, allowing researchers to:

• De-risk experimental design
• Generate convincing preliminary data
• Strengthen ARC, NHMRC, and translational grant applications

Clinical impact:
High-quality pilot data reduces uncertainty and accelerates progression to larger, funded studies.

Complex clinical questions rarely have single-dimensional answers.

10x Genomics workflows support:

• Integration of transcriptomics, immune profiling, and spatial biology
• Cross-platform studies linking cell state, location, and function
• More comprehensive biological models of disease

Clinical impact:
Multi-modal data improves robustness, reproducibility, and translational relevance which is increasingly expected by reviewers and collaborators.

Clinical research demands consistency, robustness, and scalability.

10x Genomics technologies are:

• Highly standardised and widely adopted
• Supported by validated workflows and protocols
• Designed for reproducible data generation across sites

Clinical impact:
Standardisation supports multi-centre studies and facilitates collaboration between hospitals, academia, and industry.